Interceptor Plus (Milbemycin Oxime/Praziquantel)

Interceptor Plus is a monthly chewable tablet used for the prevention of heartworm disease and the treatment of common intestinal parasites in dogs. The brand has a long history in veterinary medicine, known for its focus on pet health and parasite prevention through advanced pharmaceutical formulations.

The product was originally developed and marketed by Novartis Animal Health. However, following a series of corporate acquisitions in the mid-2010s, the brand transitioned to its current ownership. Today, the product is manufactured under strict quality control standards, primarily in the United States, to ensure safety and efficacy for pets.

The brand is currently owned by Elanco Animal Health, a major global leader in animal pharmaceuticals. Elanco, which was formerly a division of Eli Lilly and Company, operates as a standalone public entity. They manage the global distribution and manufacturing of the Interceptor line, maintaining its status as a trusted name in veterinary clinics worldwide.